| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.38▲ | 1.37▲ | 1.40▼ | 1.41▼ | 1.32▲ |
| MA10 | 1.40▼ | 1.40▼ | 1.40▼ | 1.36▲ | 1.43▼ |
| MA20 | 1.39▼ | 1.39▼ | 1.39▼ | 1.29▲ | 2.01▼ |
| MA50 | 1.36▲ | 1.31▲ | 1.29▲ | 1.49▼ | 3.09▼ |
| MA100 | 1.27▲ | 1.31▲ | 1.36▲ | 2.12▼ | 2.25▼ |
| MA200 | 1.35▲ | 1.46▼ | 1.54▼ | 2.95▼ | 2.28▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.008▼ | -0.007▼ | 0.037▲ | -0.019▼ |
| RSI | 50.038▲ | 51.693▲ | 52.356▲ | 49.380▼ | 34.693▼ |
| STOCH | 20.290 | 27.467 | 50.237 | 78.514 | 21.864 |
| WILL %R | -73.913 | -65.385 | -62.963 | -27.027 | -81.169▼ |
| CCI | -59.394 | -20.320 | -10.710 | 52.489 | -50.235 |
|
Tuesday, June 15, 2021 05:30 AM
Results demonstrate continued increased awareness and intent to prescribe GIMOTISOLANA BEACH, Calif. and CHICAGO, June 15, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: EVOK), a specialty pharmaceutical company ...
|
|
Tuesday, June 08, 2021 05:30 AM
Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal ...
|
|
Tuesday, June 08, 2021 05:30 AM
FDA approved the New Drug Application for Gimoti in June 2020. As previously announced on June 2, 2021, the United States Patent and Trademark Office (USPTO) issued US patent No. 11,020,361 entitled ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/06/21 | 1.36 | 1.39 | 1.35 | 1.38 | 609,745 |
| 14/06/21 | 1.43 | 1.48 | 1.41 | 1.42 | 202,114 |
| 11/06/21 | 1.43 | 1.45 | 1.37 | 1.43 | 199,510 |
| 10/06/21 | 1.37 | 1.48 | 1.32 | 1.46 | 588,702 |
| 09/06/21 | 1.38 | 1.41 | 1.36 | 1.36 | 281,200 |
| 08/06/21 | 1.34 | 1.40 | 1.30 | 1.38 | 440,163 |
| 07/06/21 | 1.31 | 1.33 | 1.27 | 1.31 | 253,882 |
| 04/06/21 | 1.27 | 1.30 | 1.24 | 1.29 | 121,976 |
| 03/06/21 | 1.30 | 1.31 | 1.23 | 1.27 | 287,823 |
| 02/06/21 | 1.36 | 1.42 | 1.25 | 1.29 | 785,055 |
|
|
||||
|
|
||||
|
|